Ezetimibe Impurity 20 | CAS 928045-10-7 - Request Quote
Ezetimibe Impurity 20
| SZ CAT No: | SZ-E026070 |
| CAS No | 928045-10-7 |
| Mol.F. | C31H25F2NO3 |
| Mol.Wt. | 497.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 20 is chemically (3S,4R)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one. Ezetimibe Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 928045-10-7
Purchase 928045-10-7
Order 928045-10-7
Enquire 928045-10-7
price of 928045-10-7
928045-10-7 Supplier
928045-10-7 Manufacturer
928045-10-7 Exporter
buy high quality Ezetimibe Impurity 20
Purchase Ezetimibe Impurity 20
Ezetimibe Impurity 20 suppliers
Ezetimibe Impurity 20 manufacturers
Ezetimibe Impurity 20 price
Order Ezetimibe Impurity 20
Enquire Ezetimibe Impurity 20
Ezetimibe Impurity 20 cost
Ezetimibe Impurity 20 Supplier
Ezetimibe Impurity 20 Distributor
Ezetimibe Impurity 20 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 20 for ANDA Filing
Ezetimibe Impurity 20 for Forced Degradation Studies
Ezetimibe Impurity 20 Identification Standards
Ezetimibe Impurity 20 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.